HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G.

AbstractOBJECTIVE:
In this study, we tested the hypothesis that 17beta-estradiol (E2) administration after trauma-hemorrhage reduces lung injury through a mechanism involving estrogen receptor (ER)-dependent activation of the endothelial nitric oxide (NO) synthase (eNOS)/protein kinase G (PKG)/vasodilator-stimulated phosphoprotein (VASP) pathway.
BACKGROUND:
Estrogen provides protection after injury via activation of multiple signaling cascades, including the cyclic GMP-dependent PKG pathway. Phosphorylation of VASP at Ser239 (p-VASP) can be used to assess PKG signaling activity.
METHODS:
Male Sprague-Dawley rats (275-325 g) underwent soft tissue trauma (midline laparotomy) and hemorrhagic shock (mean blood pressure 35-40 mm Hg for 90 minutes) followed by fluid resuscitation. Animals were pretreated with a nonselective NOS inhibitor (N(omega)-nitro-L-arginine methyl ester; 30 mg/kg), a soluble guanylyl cyclase (sGC) inhibitor [1H-(1, 2, 4) oxadiazolo (3, 4-alpha) quinoxalin-1-one; 10 mg/kg] or an ER antagonist (ICI 182,780; 3 mg/kg) 30 minutes before E2 (100 microg/kg) or vehicle administration. Animals were killed at 2 hours after resuscitation.
RESULTS:
Lung injury induced by trauma-hemorrhage is evidenced by edema (wet/dry ratio), neutrophil infiltration (myeloperoxidase activity), and with an increased expression of cytokines, chemokines, and adhesion molecules. E2 treatment after trauma-hemorrhage resulted in an increase in eNOS expression/phosphorylation, PKG-I activation, and VASP/p-VASP expression, which paralleled a decrease in lung injury. Inhibition of NOS and sGC abolished the E2-induced increase in PKG-I activity, VASP/p-VASP expression. Blockade of eNOS, PKG-I, and ER exacerbated lung inflammation and injury.
CONCLUSIONS:
These results collectively suggest that activation of the eNOS-PKG/VASP pathway by E2 protects against trauma-hemorrhage-induced lung injury.
AuthorsWen-Hong Kan, Jun-Te Hsu, Martin G Schwacha, Mashkoor A Choudhry, Kirby I Bland, Irshad H Chaudry
JournalAnnals of surgery (Ann Surg) Vol. 248 Issue 2 Pg. 294-302 (Aug 2008) ISSN: 1528-1140 [Electronic] United States
PMID18650641 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cell Adhesion Molecules
  • Chemokines
  • Cytokines
  • Estrogen Antagonists
  • Inflammation Mediators
  • Microfilament Proteins
  • Phosphoproteins
  • vasodilator-stimulated phosphoprotein
  • Nitric Oxide Synthase Type III
  • Cyclic GMP-Dependent Protein Kinases
Topics
  • Analysis of Variance
  • Animals
  • Blotting, Western
  • Cell Adhesion Molecules (drug effects, metabolism)
  • Chemokines (analysis, metabolism)
  • Cyclic GMP-Dependent Protein Kinases (drug effects, metabolism)
  • Cytokines (analysis, metabolism)
  • Disease Models, Animal
  • Estrogen Antagonists (pharmacology)
  • Inflammation Mediators (metabolism)
  • Lung Diseases (prevention & control)
  • Lung Injury
  • Male
  • Microfilament Proteins (drug effects, metabolism)
  • Nitric Oxide Synthase Type III (drug effects, metabolism)
  • Phosphoproteins (drug effects, metabolism)
  • Probability
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Sensitivity and Specificity
  • Shock, Hemorrhagic (complications)
  • Signal Transduction
  • Wounds and Injuries (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: